<DOC>
	<DOCNO>NCT01316302</DOCNO>
	<brief_summary>This study design evaluate efficacy safety Pristiq® treatment symptom Generalized Social Anxiety Disorder ( SAD ) .</brief_summary>
	<brief_title>12-Week Study Pristiq ( Desvenlafaxine ) Social Anxiety Disorder</brief_title>
	<detailed_description>Social Anxiety Disorder ( SAD ) recognize prevalent , chronic disable condition . Lifetime prevalence estimate 13 % National Comorbidity Survey . There good reason think Pristiq® would effective Social Anxiety Disorder . Effexor XR , mechanistically similar Pristiq® , find effective subject Generalized Social Anxiety Disorder five placebo control trial study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Subjects must give write informed consent prior study procedure . Diagnosis Social Anxiety Disorder ( SAD ) ( 300.23 Social Phobia/Social Anxiety Disorder , Generalized Subtype ) accord DSMIVTR criterion , determine psychiatric evaluation Principal Investigator . A minimum score 60 LSAS total score Screening Baseline visit . A total HAMD score le 15 Screening visit . CGI Severity score 4 great Screening Baseline visit . Female subject childbearing potential must commit effective form contraception duration trial . Effective form contraception include : condom spermicide , diaphragm spermicide , hormonal contraceptive agent ( oral , transdermal , injectable ) , implantable contraceptive device . An Axis I disorder SAD ( e.g. , posttraumatic stress disorder , obsessive compulsive disorder , panic disorder ) within 24 week Baseline visit . Subjects comorbid MDD , GAD , dysthymia , specific phobia allow GSAD primary disorder term clinical severity , determine investigator . Any history complication schizophrenia bipolar disorder . Any complication body dysmorphic disorder . Substance dependence , define DSMIVTR criterion , within 24 week Baseline visit . Subjects currently pregnant , lactate , childbearing potential practicing effective method contraception . Subjects score &gt; 2 item # 3 HAMD , , opinion PI , clinically significant risk suicide . Systolic blood pressure ≥165 and/or diastolic blood pressure ≥95 . Positive Urine Drug Screen Screening visit . Any current unstable and/or clinically significant medical condition , base history evidence Screening laboratory ECG assessment . Any history complication cancer malignant tumor . Fluoxetine within 28 day Baseline MAO inhibitor within 14 day Baseline Any psychotropics ( include SSRIs , SNRIs , benzodiazepine ) within 14 day Baseline . Zolpidem ( Ambien® ) PRN allow insomnia take 3 time per week . Subjects start psychotherapy cognitivebehavioral therapy within 24 week Baseline visit , except supportive psychotherapy . Electroconvulsive therapy ( ECT ) within 12 week Baseline visit . Treatment refractory GSAD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Social Phobia</keyword>
	<keyword>SAD</keyword>
</DOC>